Walleye Capital
SION

Walleye Capital’s Sionna Therapeutics SION Stock Holding History

Walleye Capital’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$605K Buy
+15,097
New +$576K ﹤0.01% 2508

Other funds holding SION

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Walleye Capital's SION Position: Q1 2026 in Review

Walleye Capital opened a new position in Sionna Therapeutics (SION) in Q1 2026: 15,097 shares worth $605K. The stake represents ﹤0.01% of the portfolio and ranks #2508 among its holdings.

122 funds tracked by Wall St. Rank hold SION as of Q1 2026.

  • Walleye Capital held 15,097 shares of Sionna Therapeutics worth $605K as of Q1 2026.
  • Sionna Therapeutics was a new Walleye Capital position in Q1 2026.
  • Sionna Therapeutics made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2508 holding.
  • 122 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.